{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T19:52:13Z","timestamp":1772135533269,"version":"3.50.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000093","name":"U.S. Department of Health & Human Services | NIH | Center for Information Technology","doi-asserted-by":"publisher","award":["1-ZIA-BC011979-02"],"award-info":[{"award-number":["1-ZIA-BC011979-02"]}],"id":[{"id":"10.13039\/100000093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Prostate cancer (PrCa) incidence and severity vary across ancestries; men of African ancestry (AA) are more likely to be diagnosed and die from PrCa than those of European ancestry (EA). Current polygenic risk scores, even from multi-ancestry GWAS, do not fully capture population-specific genetic mechanisms, especially those mediated by non-coding regulatory single nucleotide polymorphisms (SNPs). Using a deep learning model of prostate enhancers, we identify ~ 2000 SNPs, potentially affecting enhancer function, with higher alternate allele frequency in AA men, that may affect PrCa risk. These SNPs may promote cancer via two mechanisms: increased enhancer activity leading to immune suppression and telomere elongation or decreased activity causing de-differentiation and apoptosis inhibition. Identified SNPs predominantly modulate binding of key transcription factors such as FOX, HOX, and AR \u2013 the first was experimentally validated. Incorporating these SNPs into a polygenic risk score improves PrCa risk assessment beyond existing GWAS-identified variants.<\/jats:p>","DOI":"10.1038\/s41467-025-64631-4","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T11:40:52Z","timestamp":1763638852000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Non-coding genetic variants underlying higher prostate cancer risk in men of African ancestry"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6760-0711","authenticated-orcid":false,"given":"Shan","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8552-2846","authenticated-orcid":false,"given":"Kaniz","family":"Fatema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nidharshan","family":"Sundarraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6087-7240","authenticated-orcid":false,"given":"Arashdeep","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0489-0819","authenticated-orcid":false,"given":"Padma Sheila","family":"Rajagopal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9460-8070","authenticated-orcid":false,"given":"Dimple","family":"Notani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5986-1169","authenticated-orcid":false,"given":"David Y.","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9603-7569","authenticated-orcid":false,"given":"Sridhar","family":"Hannenhalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"key":"64631_CR1","doi-asserted-by":"crossref","unstructured":"Saunders, E. J., Kote-Jarai, Z. & Eeles, R. A. Identification of germline genetic variants that increase prostate cancer risk and influence development of aggressive disease. Cancers 13, 760 (2021).","DOI":"10.3390\/cancers13040760"},{"key":"64631_CR2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41588-020-00748-0","volume":"53","author":"DV Conti","year":"2021","unstructured":"Conti, D. V. et al. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction. Nat. Genet. 53, 65\u201375 (2021).","journal-title":"Nat. Genet."},{"key":"64631_CR3","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1177\/1557988318798279","volume":"12","author":"HE Taitt","year":"2018","unstructured":"Taitt, H. E. Global trends and prostate cancer: a review of incidence, detection, and mortality as influenced by race, ethnicity, and geographic location. Am. J. Mens. Health 12, 1807\u20131823 (2018).","journal-title":"Am. J. Mens. Health"},{"key":"64631_CR4","doi-asserted-by":"publisher","first-page":"14068","DOI":"10.1073\/pnas.0605832103","volume":"103","author":"ML Freedman","year":"2006","unstructured":"Freedman, M. L. et al. Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men. Proc. Natl. Acad. Sci. USA 103, 14068\u201314073 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"64631_CR5","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/ng2015","volume":"39","author":"CA Haiman","year":"2007","unstructured":"Haiman, C. A. et al. Multiple regions within 8q24 independently affect risk for prostate cancer. Nat. Genet 39, 638\u2013644 (2007).","journal-title":"Nat. Genet"},{"key":"64631_CR6","doi-asserted-by":"publisher","first-page":"e2433546","DOI":"10.1001\/jamanetworkopen.2024.33546","volume":"7","author":"CM Pichardo","year":"2024","unstructured":"Pichardo, C. M. et al. West African genetic ancestry, neighborhood deprivation, and prostate cancer. JAMA Netw. Open 7, e2433546 (2024).","journal-title":"JAMA Netw. Open"},{"key":"64631_CR7","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1038\/s41588-022-01168-y","volume":"54","author":"SC Baca","year":"2022","unstructured":"Baca, S. C. et al. Genetic determinants of chromatin reveal prostate cancer risk mediated by context-dependent gene regulation. Nat. Genet. 54, 1364\u20131375 (2022).","journal-title":"Nat. Genet."},{"key":"64631_CR8","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1038\/s41588-023-01534-4","volume":"55","author":"A Wang","year":"2023","unstructured":"Wang, A. et al. Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants. Nat. Genet. 55, 2065\u20132074 (2023).","journal-title":"Nat. Genet."},{"key":"64631_CR9","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s00439-013-1387-z","volume":"133","author":"MB Cook","year":"2014","unstructured":"Cook, M. B. et al. A genome-wide association study of prostate cancer in West African men. Hum. Genet. 133, 509\u2013521 (2014).","journal-title":"Hum. Genet."},{"key":"64631_CR10","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/s41588-018-0142-8","volume":"50","author":"FR Schumacher","year":"2018","unstructured":"Schumacher, F. R. et al. Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. Nat. Genet. 50, 928\u2013936 (2018).","journal-title":"Nat. Genet."},{"key":"64631_CR11","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/s41576-018-0018-x","volume":"19","author":"A Torkamani","year":"2018","unstructured":"Torkamani, A., Wineinger, N. E. & Topol, E. J. The personal and clinical utility of polygenic risk scores. Nat. Rev. Genet. 19, 581\u2013590 (2018).","journal-title":"Nat. Rev. Genet."},{"key":"64631_CR12","doi-asserted-by":"crossref","unstructured":"Brown, B. C., Ye, C. J., Price, A. L. & Zaitlen, N. Asian genetic epidemiology network type 2 diabetes Transethnic Genetic-Correlation Estimates from Summary Statistics. Am. J. Hum. Genet 99, 76\u201388 (2016).","DOI":"10.1016\/j.ajhg.2016.05.001"},{"key":"64631_CR13","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s41588-022-01054-7","volume":"54","author":"Y Ruan","year":"2022","unstructured":"Ruan, Y. et al. Improving polygenic prediction in ancestrally diverse populations. Nat. Genet. 54, 573\u2013580 (2022).","journal-title":"Nat. Genet."},{"key":"64631_CR14","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.ajhg.2023.05.010","volume":"110","author":"BF Darst","year":"2023","unstructured":"Darst, B. F. et al. Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry. Am. J. Hum. Genet. 110, 1200\u20131206 (2023).","journal-title":"Am. J. Hum. Genet."},{"key":"64631_CR15","unstructured":"Conti, D. V. et al. Two novel susceptibility loci for prostate cancer in men of African ancestry. J. Natl. Cancer Inst. 109, djx084 (2017)."},{"key":"64631_CR16","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.eururo.2020.04.060","volume":"78","author":"BF Darst","year":"2020","unstructured":"Darst, B. F. et al. A germline variant at 8q24 contributes to familial clustering of prostate cancer in men of African ancestry. Eur. Urol. 78, 316\u2013320 (2020).","journal-title":"Eur. Urol."},{"key":"64631_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17325-y","volume":"11","author":"K Walavalkar","year":"2020","unstructured":"Walavalkar, K. et al. A rare variant of African ancestry activates 8q24 lncRNA hub by modulating cancer associated enhancer. Nat. Commun. 11, 3598 (2020).","journal-title":"Nat. Commun."},{"key":"64631_CR18","doi-asserted-by":"publisher","first-page":"eadd2911","DOI":"10.1126\/sciadv.add2911","volume":"9","author":"S Li","year":"2023","unstructured":"Li, S., Hannenhalli, S. & Ovcharenko, I. De novo human brain enhancers created by single-nucleotide mutations. Sci. Adv. 9, eadd2911 (2023).","journal-title":"Sci. Adv."},{"key":"64631_CR19","first-page":"1809","volume":"43","author":"JS Horoszewicz","year":"1983","unstructured":"Horoszewicz, J. S. et al. LNCaP model of human prostatic carcinoma. Cancer Res. 43, 1809\u20131818 (1983).","journal-title":"Cancer Res."},{"key":"64631_CR20","first-page":"2493","volume":"3","author":"NM Navone","year":"1997","unstructured":"Navone, N. M. et al. Establishment of two human prostate cancer cell lines derived from a single bone metastasis. Clin. Cancer Res. 3, 2493\u20132500 (1997).","journal-title":"Clin. Cancer Res."},{"key":"64631_CR21","doi-asserted-by":"publisher","first-page":"e1004102","DOI":"10.1371\/journal.pgen.1004102","volume":"10","author":"DJ Hazelett","year":"2014","unstructured":"Hazelett, D. J. et al. Comprehensive functional annotation of 77 prostate cancer risk loci. PLoS Genet. 10, e1004102 (2014).","journal-title":"PLoS Genet."},{"key":"64631_CR22","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1038\/s41588-019-0455-2","volume":"51","author":"J van Arensbergen","year":"2019","unstructured":"van Arensbergen, J. et al. High-throughput identification of human SNPs affecting regulatory element activity. Nat. Genet. 51, 1160\u20131169 (2019).","journal-title":"Nat. Genet."},{"key":"64631_CR23","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nbt.1630","volume":"28","author":"CY McLean","year":"2010","unstructured":"McLean, C. Y. et al. GREAT improves functional interpretation of cis-regulatory regions. Nat. Biotechnol. 28, 495\u2013501 (2010).","journal-title":"Nat. Biotechnol."},{"key":"64631_CR24","doi-asserted-by":"publisher","first-page":"e1010378","DOI":"10.1371\/journal.pcbi.1010378","volume":"18","author":"Y Tanigawa","year":"2022","unstructured":"Tanigawa, Y., Dyer, E. S. & Bejerano, G. WhichTF is functionally important in your open chromatin data? PLoS Comput. Biol. 18, e1010378 (2022).","journal-title":"PLoS Comput. Biol."},{"key":"64631_CR25","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1158\/1078-0432.CCR-20-2925","volume":"27","author":"S Awasthi","year":"2021","unstructured":"Awasthi, S. et al. Comparative genomics reveals distinct immune-oncologic pathways in African American men with prostate cancer. Clin. Cancer Res. 27, 320\u2013329 (2021).","journal-title":"Clin. Cancer Res."},{"key":"64631_CR26","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang, P. et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat. Med. 24, 1550\u20131558 (2018).","journal-title":"Nat. Med."},{"key":"64631_CR27","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1126\/science.ado0431","volume":"384","author":"K Karimian","year":"2024","unstructured":"Karimian, K. et al. Human telomere length is chromosome end-specific and conserved across individuals. Science 384, 533\u2013539 (2024).","journal-title":"Science"},{"key":"64631_CR28","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1001\/jamaoncol.2016.5945","volume":"3","author":"C Telomeres Mendelian Randomization","year":"2017","unstructured":"Telomeres Mendelian Randomization, C. et al. Association between telomere length and risk of cancer and non-neoplastic diseases: a mendelian randomization study. JAMA Oncol. 3, 636\u2013651 (2017).","journal-title":"JAMA Oncol."},{"key":"64631_CR29","doi-asserted-by":"crossref","unstructured":"Demanelis, K. et al. Determinants of telomere length across human tissues. Science 369, eaaz6876 (2020).","DOI":"10.1101\/793406"},{"key":"64631_CR30","doi-asserted-by":"publisher","first-page":"4713","DOI":"10.1016\/j.cell.2024.06.012","volume":"187","author":"J Yu","year":"2024","unstructured":"Yu, J. et al. Progestogen-driven B7-H4 contributes to onco-fetal immune tolerance. Cell 187, 4713\u20134732.e19 (2024).","journal-title":"Cell"},{"key":"64631_CR31","doi-asserted-by":"crossref","unstructured":"Aghaeepour, N. et al. An immune clock of human pregnancy. Sci. Immunol. 2, eaan2946 (2017).","DOI":"10.1126\/sciimmunol.aan2946"},{"key":"64631_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-014-0085-3","volume":"6","author":"O Corradin","year":"2014","unstructured":"Corradin, O. & Scacheri, P. C. Enhancer variants: evaluating functions in common disease. Genome Med. 6, 85 (2014).","journal-title":"Genome Med."},{"key":"64631_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36535-8","volume":"14","author":"S Carrasco Pro","year":"2023","unstructured":"Carrasco Pro, S. et al. Widespread perturbation of ETS factor binding sites in cancer. Nat. Commun. 14, 913 (2023).","journal-title":"Nat. Commun."},{"key":"64631_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-025-11374-7","volume":"26","author":"M Hoffmann","year":"2025","unstructured":"Hoffmann, M., Vaz, T., Chhatrala, S. & Hennighausen, L. Data-driven projections of candidate enhancer-activating SNPs in immune regulation. BMC Genom. 26, 197 (2025).","journal-title":"BMC Genom."},{"key":"64631_CR35","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1101\/gr.276064.121","volume":"32","author":"A Toropainen","year":"2022","unstructured":"Toropainen, A. et al. Functional noncoding SNPs in human endothelial cells fine-map vascular trait associations. Genome Res. 32, 409\u2013424 (2022).","journal-title":"Genome Res."},{"key":"64631_CR36","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s13238-020-00786-8","volume":"12","author":"M Teng","year":"2021","unstructured":"Teng, M., Zhou, S., Cai, C., Lupien, M. & He, H. H. Pioneer of prostate cancer: past, present and the future of FOXA1. Protein Cell 12, 29\u201338 (2021).","journal-title":"Protein Cell"},{"key":"64631_CR37","doi-asserted-by":"publisher","first-page":"D900","DOI":"10.1093\/nar\/gky939","volume":"47","author":"H Yuan","year":"2019","unstructured":"Yuan, H. et al. CancerSEA: a cancer single-cell state atlas. Nucleic Acids Res. 47, D900\u2013D908 (2019).","journal-title":"Nucleic Acids Res."},{"key":"64631_CR38","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.humpath.2009.07.011","volume":"41","author":"Y Song","year":"2010","unstructured":"Song, Y. et al. N-myc downstream regulated gene-1\/Cap43 may play an important role in malignant progression of prostate cancer, in its close association with E-cadherin. Hum. Pathol. 41, 214\u2013222 (2010).","journal-title":"Hum. Pathol."},{"key":"64631_CR39","doi-asserted-by":"crossref","unstructured":"Joshi, V., Lakhani, S. R. & McCart Reed, A. E. NDRG1 in Cancer: a Suppressor, Promoter, or Both? Cancers 14, 5739 (2022).","DOI":"10.3390\/cancers14235739"},{"key":"64631_CR40","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/s41586-019-1318-9","volume":"571","author":"EJ Adams","year":"2019","unstructured":"Adams, E. J. et al. FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes. Nature 571, 408\u2013412 (2019).","journal-title":"Nature"},{"key":"64631_CR41","doi-asserted-by":"publisher","first-page":"100773","DOI":"10.1016\/j.tranon.2020.100773","volume":"13","author":"D Ribatti","year":"2020","unstructured":"Ribatti, D., Tamma, R. & Annese, T. Epithelial-mesenchymal transition in cancer: a historical overview. Transl. Oncol. 13, 100773 (2020).","journal-title":"Transl. Oncol."},{"key":"64631_CR42","doi-asserted-by":"crossref","unstructured":"Muz, B., de la Puente, P., Azab, F. & Azab, A. K. The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy. Hypoxia 3, 83\u201392 (2015).","DOI":"10.2147\/HP.S93413"},{"key":"64631_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0919-9","volume":"9","author":"FO Enane","year":"2018","unstructured":"Enane, F. O., Saunthararajah, Y. & Korc, M. Differentiation therapy and the mechanisms that terminate cancer cell proliferation without harming normal cells. Cell Death Dis. 9, 912 (2018).","journal-title":"Cell Death Dis."},{"key":"64631_CR44","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.canlet.2021.07.045","volume":"520","author":"KJ Campbell","year":"2021","unstructured":"Campbell, K. J. & Leung, H. Y. Evasion of cell death: a contributory factor in prostate cancer development and treatment resistance. Cancer Lett. 520, 213\u2013221 (2021).","journal-title":"Cancer Lett."},{"key":"64631_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11526-w","volume":"10","author":"M Kircher","year":"2019","unstructured":"Kircher, M. et al. Saturation mutagenesis of twenty disease-associated regulatory elements at single base-pair resolution. Nat. Commun. 10, 3583 (2019).","journal-title":"Nat. Commun."},{"key":"64631_CR46","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/nmeth.3547","volume":"12","author":"J Zhou","year":"2015","unstructured":"Zhou, J. & Troyanskaya, O. G. Predicting effects of noncoding variants with deep learning-based sequence model. Nat. Methods 12, 931\u2013934 (2015).","journal-title":"Nat. Methods"},{"key":"64631_CR47","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1038\/s41588-018-0160-6","volume":"50","author":"J Zhou","year":"2018","unstructured":"Zhou, J. et al. Deep learning sequence-based ab initio prediction of variant effects on expression and disease risk. Nat. Genet. 50, 1171\u20131179 (2018).","journal-title":"Nat. Genet."},{"key":"64631_CR48","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114\u20132120 (2014).","journal-title":"Bioinformatics"},{"key":"64631_CR49","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357\u2013359 (2012).","journal-title":"Nat. Methods"},{"key":"64631_CR50","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. et al. The sequence alignment\/map format and SAMtools. Bioinformatics 25, 2078\u20132079 (2009).","journal-title":"Bioinformatics"},{"key":"64631_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2008-9-9-r137","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137 (2008).","journal-title":"Genome Biol."},{"key":"64631_CR52","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nature14248","volume":"518","author":"A Kundaje","year":"2015","unstructured":"Kundaje, A. et al. Integrative analysis of 111 reference human epigenomes. Nature 518, 317\u2013330 (2015).","journal-title":"Nature"},{"key":"64631_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1165-7","volume":"18","author":"I de Santiago","year":"2017","unstructured":"de Santiago, I. et al. BaalChIP: Bayesian analysis of allele-specific transcription factor binding in cancer genomes. Genome Biol. 18, 39 (2017).","journal-title":"Genome Biol."},{"key":"64631_CR54","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1038\/onc.2011.312","volume":"31","author":"B Orr","year":"2012","unstructured":"Orr, B. et al. Identification of stromally expressed molecules in the prostate by tag-profiling of cancer-associated fibroblasts, normal fibroblasts and fetal prostate. Oncogene 31, 1130\u20131142 (2012).","journal-title":"Oncogene"},{"key":"64631_CR55","doi-asserted-by":"publisher","first-page":"W202","DOI":"10.1093\/nar\/gkp335","volume":"37","author":"TL Bailey","year":"2009","unstructured":"Bailey, T. L. et al. MEME SUITE: tools for motif discovery and searching. Nucleic Acids Res. 37, W202\u2013W208 (2009).","journal-title":"Nucleic Acids Res."},{"key":"64631_CR56","doi-asserted-by":"publisher","first-page":"D142","DOI":"10.1093\/nar\/gkt997","volume":"42","author":"A Mathelier","year":"2014","unstructured":"Mathelier, A. et al. JASPAR 2014: an extensively expanded and updated open-access database of transcription factor binding profiles. Nucleic Acids Res. 42, D142\u2013D147 (2014).","journal-title":"Nucleic Acids Res."},{"key":"64631_CR57","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1016\/j.cell.2014.08.009","volume":"158","author":"MT Weirauch","year":"2014","unstructured":"Weirauch, M. T. et al. Determination and inference of eukaryotic transcription factor sequence specificity. Cell 158, 1431\u20131443 (2014).","journal-title":"Cell"},{"key":"64631_CR58","doi-asserted-by":"publisher","first-page":"D127","DOI":"10.1093\/nar\/gkl857","volume":"35","author":"M Pachkov","year":"2007","unstructured":"Pachkov, M., Erb, I., Molina, N. & van Nimwegen, E. SwissRegulon: a database of genome-wide annotations of regulatory sites. Nucleic Acids Res. 35, D127\u2013D131 (2007).","journal-title":"Nucleic Acids Res."},{"key":"64631_CR59","doi-asserted-by":"publisher","first-page":"D116","DOI":"10.1093\/nar\/gkv1249","volume":"44","author":"IV Kulakovskiy","year":"2016","unstructured":"Kulakovskiy, I. V. et al. HOCOMOCO: expansion and enhancement of the collection of transcription factor binding sites models. Nucleic Acids Res. 44, D116\u2013D125 (2016).","journal-title":"Nucleic Acids Res."},{"key":"64631_CR60","doi-asserted-by":"publisher","first-page":"D117","DOI":"10.1093\/nar\/gku1045","volume":"43","author":"MA Hume","year":"2015","unstructured":"Hume, M. A., Barrera, L. A., Gisselbrecht, S. S. & Bulyk, M. L. UniPROBE, update 2015: new tools and content for the online database of protein-binding microarray data on protein-DNA interactions. Nucleic Acids Res. 43, D117\u2013D122 (2015).","journal-title":"Nucleic Acids Res."},{"key":"64631_CR61","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/ng.3656","volume":"48","author":"S Das","year":"2016","unstructured":"Das, S. et al. Next-generation genotype imputation service and methods. Nat. Genet. 48, 1284\u20131287 (2016).","journal-title":"Nat. Genet."},{"key":"64631_CR62","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","volume":"526","author":"A Auton","year":"2015","unstructured":"Auton, A. et al. A global reference for human genetic variation. Nature 526, 68\u201374 (2015).","journal-title":"Nature"},{"key":"64631_CR63","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1101\/gr.133280.111","volume":"22","author":"HH He","year":"2012","unstructured":"He, H. H. et al. Differential DNase I hypersensitivity reveals factor-dependent chromatin dynamics. Genome Res. 22, 1015\u20131025 (2012).","journal-title":"Genome Res."},{"key":"64631_CR64","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/s41588-020-0664-8","volume":"52","author":"MM Pomerantz","year":"2020","unstructured":"Pomerantz, M. M. et al. Prostate cancer reactivates developmental epigenomic programs during metastatic progression. Nat. Genet. 52, 790\u2013799 (2020).","journal-title":"Nat. Genet."},{"key":"64631_CR65","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/j.ajhg.2021.11.007","volume":"108","author":"C Giambartolomei","year":"2021","unstructured":"Giambartolomei, C. et al. H3K27ac HiChIP in prostate cell lines identifies risk genes for prostate cancer susceptibility. Am. J. Hum. Genet. 108, 2284\u20132300 (2021).","journal-title":"Am. J. Hum. Genet."},{"key":"64631_CR66","doi-asserted-by":"publisher","first-page":"W158","DOI":"10.1093\/nar\/gkz348","volume":"47","author":"D Li","year":"2019","unstructured":"Li, D., Hsu, S., Purushotham, D., Sears, R. L. & Wang, T. WashU epigenome browser update 2019. Nucleic Acids Res. 47, W158\u2013W165 (2019).","journal-title":"Nucleic Acids Res."},{"key":"64631_CR67","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.cell.2017.06.010","volume":"170","author":"A Tsherniak","year":"2017","unstructured":"Tsherniak, A. et al. Defining a cancer dependency map. Cell 170, 564\u2013576 e16 (2017).","journal-title":"Cell"},{"key":"64631_CR68","doi-asserted-by":"publisher","unstructured":"Li, S. et al. Non-coding genetic variants underlying higher prostate cancer risk in men of African ancestry. Zenodo. https:\/\/doi.org\/10.5281\/zenodo.17178792 (2025).","DOI":"10.5281\/zenodo.17178792"},{"key":"64631_CR69","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/bib\/bbs038","volume":"14","author":"RM Kuhn","year":"2013","unstructured":"Kuhn, R. M., Haussler, D. & Kent, W. J. The UCSC genome browser and associated tools. Br. Bioinform 14, 144\u2013161 (2013).","journal-title":"Br. Bioinform"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64631-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64631-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64631-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T13:05:24Z","timestamp":1763643924000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64631-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["64631"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-64631-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5485172\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"assertion":[{"value":"22 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10202"}}